← Back to searchRecruitingRecruiting
Telehealth Behavioral Activation for Teens
NCT06273995 · Baylor College of Medicine
In plain English
Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.
About this study
Rates of youth depression and suicide are rising worldwide and present a critical public health problem. Between 2007 and 2018, rates of fatal suicide among U.S. youth and young adults increased by 57.4%, becoming the second leading cause of all deaths for Americans between the ages of 10 and 34 in 2020. Similarly, between 2009 and 2019, rates of past year major depressive episodes among adolescents in the United States increased from 8.1% to 15.8% (roughly 1 in 6). Despite these high rates of suicide and depression, Texas is rated 51st in access to mental healthcare in the United States. As untreated youth depression tends to persist and has been related to poorer functioning in adulthood, there is a need to increase access to empirically supported treatment for depressed adolescents.
Behavioral activation is one such empirically supported intervention. Derived from cognitive-behavioral therapy, a well-established treatment for depression, behavioral activation uses psychoeducation and skill-building to increase an individual's engagement in valued and enjoyable activities (e.g., socializing with family and friends, exercising, participating in a hobby) in order to improve depressive symptoms. Research has shown that behavioral activation is an effective intervention for depressed youth. Additionally, it has been shown as a promising intervention that can be conducted in a brief, virtual format and can be effectively implemented by both trained clinicians and trained, non-licensed interventionists.
Eligibility criteria
Inclusion Criteria:
1. Participants must be enrolled in the Texas Youth Depression Suicide Research Network (TX-YDSRN) Registry Study;
2. Be between the ages of 12- 18 or currently enrolled in high school;
3. Have a caregiver that is willing to participate in the program;
4. Be able to commit to weekly sessions for eight weeks;
5. Be currently experiencing depressive symptoms;
6. Be able to participate in telehealth services within the state of Texas;
7. Be willing to provide consent/assent (parents/legally authorized representative (LAR)/guardian or young adult participant, aged 18 or older, must be willing to provide consent; youth, aged 12-17, must be willing to provide assent);
8. Be able to read, write and speak English or Spanish sufficiently to understand the study procedures and provide written informed consent to participate in the study;
9. Be willing to dedicate appropriate time to complete scheduled study assessment and measures and attend intervention sessions (both parent/LAR/guardian and youth)
10. Be able to provide a reliable means of contact.
Exclusion Criteria:
1. Have an acute medical or psychological condition(s) that that would, in the judgment of the study medical clinician, make participation difficult or unsafe;
2. Have an acute medical or psychological condition(s) that would result in an inability to accurately complete study requirements (e.g., neurological conditions or significant neurodevelopmental concerns);
3. Have active psychotic or manic symptoms resulting in altered mental status and inability to provide assent or requiring immediate attention and/or higher level of intervention;
4. Have a parent/LAR/guardian who is deemed cognitively unable to provide consent (if youth participant, aged 12-17).
Study design
Enrollment target: 250 participants
Allocation: na
Masking: none
Age groups: child, adult
Timeline
Starts: 2024-03-01
Estimated completion: 2029-12-01
Last updated: 2025-07-20
Interventions
Other: Behavioral Activation
Primary outcomes
- • Patient Health Questionnaire 9-modified for adolescents (PHQ-A) (During treatment (every session (week) 1-10))
- • Behavioral Activation for Depression-Short Form (BAD-SF) (During treatment (every session (week) 1-10))
- • Dimensional Anhedonia Rating Scale (DARS) (Baseline (before treatment), post-treatment (session/week 11))
Sponsor
Baylor College of Medicine · other
With: University of Texas
Contacts & investigators
ContactEmily Bivins, B.S. · contact · emily.bivins@bcm.edu · 713-798-1709
ContactEric Storch, Ph.D. · contact · eric.storch@bcm.edu · (713) 798-3579
All locations (1)
Baylor College of MedicineRecruiting
Houston, Texas, United States